Establishing Composite Cognitive Endpoints for Use in Preclinical Alzheimer's Disease Trials

J Prev Alzheimers Dis. 2015 Mar;2(1):2-3. doi: 10.14283/jpad.2015.46.

Authors

J B Langbaum¹, S Hendrix², N Ayutyanont¹, D A Bennett³, R C Shah³, L L Barnes³, F Lopera⁴, E M Reiman¹, P N Tariot¹

Affiliations

¹ Banner Alzheimer's Institute, Phoenix, AZ, USA.
² Pentara Corporation, Salt Lake City, UT, USA.
³ Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
⁴ University of Antioquia, Medellin, Colombia.

No abstract available

Grants and funding